ATE186835T1 - Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport - Google Patents

Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport

Info

Publication number
ATE186835T1
ATE186835T1 AT96913866T AT96913866T ATE186835T1 AT E186835 T1 ATE186835 T1 AT E186835T1 AT 96913866 T AT96913866 T AT 96913866T AT 96913866 T AT96913866 T AT 96913866T AT E186835 T1 ATE186835 T1 AT E186835T1
Authority
AT
Austria
Prior art keywords
drug
formulations
production
medicine administration
electrical transport
Prior art date
Application number
AT96913866T
Other languages
English (en)
Inventor
Thomas Owen Murdock
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE186835T1 publication Critical patent/ATE186835T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96913866T 1995-05-03 1996-04-19 Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport ATE186835T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/433,173 US5853383A (en) 1995-05-03 1995-05-03 Preparation for formulations for electrotransport drug delivery

Publications (1)

Publication Number Publication Date
ATE186835T1 true ATE186835T1 (de) 1999-12-15

Family

ID=23719114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913866T ATE186835T1 (de) 1995-05-03 1996-04-19 Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport

Country Status (8)

Country Link
US (2) US5853383A (de)
EP (1) EP0824342B1 (de)
JP (1) JP4026850B2 (de)
AT (1) ATE186835T1 (de)
DE (1) DE69605298T2 (de)
DK (1) DK0824342T3 (de)
ES (1) ES2141496T3 (de)
WO (1) WO1996034597A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
AU754882B2 (en) * 1996-02-20 2002-11-28 Computer Motion, Inc. A method and apparatus for performing minimally invasive cardiac procedures
US6718201B1 (en) * 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
US5991655A (en) * 1997-03-03 1999-11-23 Drug Delivery Systems, Inc. Iontophoretic drug delivery device and method of manufacturing the same
US6532386B2 (en) 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
JP4180244B2 (ja) 1999-04-16 2008-11-12 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 内部センサを有する電気的な移動による送出装置系
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) * 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US7404815B2 (en) * 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6629968B1 (en) * 2000-06-30 2003-10-07 Vyteris, Inc. Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
JP4922537B2 (ja) * 2000-09-11 2012-04-25 アルザ・コーポレーシヨン 経皮性の電気輸送装置とその製造方法
US6591133B1 (en) * 2000-11-27 2003-07-08 Microlin Llc Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
WO2003047689A1 (en) * 2001-11-29 2003-06-12 Microlin Llc Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
US7567313B2 (en) * 2003-07-10 2009-07-28 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Bezel design for surface mount display modules
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
PT1684851E (pt) * 2003-11-19 2007-12-03 Alza Corp Métodos para preparação de formulações polímero tampão para aplicações de electro transporte.
US20070025869A1 (en) * 2005-07-15 2007-02-01 Gordon John H Fluid Delivery Device
US20080147186A1 (en) * 2006-12-14 2008-06-19 Joshi Ashok V Electrochemical Implant For Delivering Beneficial Agents
USD617463S1 (en) * 2008-04-16 2010-06-08 Hisamitsu Pharmaceutical Co., Inc. Combined medical patch and package
USD610690S1 (en) * 2008-04-16 2010-02-23 Hisamitsu Pharmaceutical Co., Inc. Combined medical patch and package

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579283A (en) * 1950-07-21 1951-12-18 Du Pont Production of lysine monohydro-chloride
US4203440A (en) * 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
US4203441A (en) * 1978-12-18 1980-05-20 Alza Corporation Osmotically triggered device with gas generating means
US4847077A (en) * 1984-07-18 1989-07-11 Pennwalt Corporation Controlled release pharmaceutical preparations
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
EP0199855A1 (de) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Trimethoprim und ein Sulfonamid enthaltende Tabletten
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
EP0318776A1 (de) * 1987-12-04 1989-06-07 Robert Tapper Verfahren und Gerät zur Verminderung des Hautverletzung bei Gebrauch von Elektroden
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0429842B1 (de) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
GB2265088B (en) * 1992-03-10 1996-02-07 Kyosti Eero Antero Kontturi Electrochemical device for drug delivery
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.

Also Published As

Publication number Publication date
EP0824342A1 (de) 1998-02-25
WO1996034597A1 (en) 1996-11-07
JPH11504923A (ja) 1999-05-11
DE69605298T2 (de) 2000-04-13
ES2141496T3 (es) 2000-03-16
US6071508A (en) 2000-06-06
DE69605298D1 (de) 1999-12-30
DK0824342T3 (da) 2000-04-03
US5853383A (en) 1998-12-29
EP0824342B1 (de) 1999-11-24
JP4026850B2 (ja) 2007-12-26

Similar Documents

Publication Publication Date Title
ATE186835T1 (de) Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport
ATE66597T1 (de) Phospholipidpartikeln mit eingeschlossenen polyen-antibiotika zur behandlung von systemischen pilzinfektionen.
PT97199A (pt) Processo para a preparacao de formulacoes farmaceuticas a base de lecticina ou um percursor de lecticina
DE69623608D1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
EP0747092A3 (de) Lösungsflüssigkeit für durch Iontophorese zugeführte Medikamente
AU1022588A (en) Ointment base and ointment
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
CA2317582A1 (en) A drug dosage form based on the teorell-meyer gradient
AU7284098A (en) Method for preventing gastritis using amylin or amylin agonists
ATE160588T1 (de) Aus bakteriellen proteinen bestehender extrakt, verfahren zur dessen herstellung und diesen extrakt enthaltende pharmazeutische zusammensetzung
DE59504367D1 (de) Verfahren und vorrichtung zur herstellung einer flächigen darreichungsform mit einer arzneimittelwirkstoffe enthaltenden zubereitung
AU6246690A (en) Protein-containing aqueous solutions
AU1022688A (en) Antibacterial lyophilized preparation
ATE94766T1 (de) Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllaurophenonoxime (hmlo).
ATE66602T1 (de) Verwendung von nitrophenylgruppen zur stimulierung der inkorporationsfaehigkeit eines arzneimittels in die empfindlichen wirtszellen.
ITMI972470A1 (it) Uso di bisfosfonati per la preparazione di medicamenti somministrabili mediante iontoforesi
ATE66611T1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties